A phase I trial investigating the pharmacokinetics of OX 27 in volunteers.

Trial Profile

A phase I trial investigating the pharmacokinetics of OX 27 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Oct 2012

At a glance

  • Drugs Sufentanil (Primary)
  • Indications Cancer pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Oct 2011 New source identified (European Clinical Trials Database record).
    • 14 Jun 2011 Pharmacokinetic outcomes were reported in an Orexo media release.
    • 01 Jun 2011 Status changed from not stated to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top